Most Recent
Law firm Herbert Smith Freehills has attacked a lawsuit brought by a group of lenders against collapsed steel giant Arrium, rejecting claims that $430 million in loans was borrowed under misleading or deceptive representations.
The former group treasurer of collapsed steel giant Arrium has hit back at claims brought by the company's liquidators that it was trading while insolvent, arguing the case had been 'infected' by evidence from an expert who was also a plaintiff in the case.
Doomed iron and steel giant Arrium attempted to stave off its inevitable $2.8 billion collapse and put off negotiating with its lenders until the last minute despite warnings from its legal and financial advisors, liquidators for the company told the court.
A former financial planner of IOOF unit RI Advice, who has been accused by ASIC of pocketing hefty commissions from clients steered to risky investments, has abandoned his defence on the second day of trial.
A financial adviser at the centre of ASIC's bad advice case against an IOOF unit might mount an argument that a fair trial is not possible because of his "fulsome" answers to investigators during a compulsory examination.
Directors of steel producer Arrium continued to borrow money from "vulnerable" lenders in the months prior to the company's $2.8 billion collapse and "bled cash" despite the inevitable end, a number of lenders have said on the first day of a 40-day trial in the NSW Supreme Court.
ASIC's warning about the futility of mediation with an IOOF subsidiary has proved prophetic, with talks last week failing to resolve the regulator's case ahead of trial starting Monday.
A judge has indicated that he will allow Arrium Group's liquidator to give expert evidence at an upcoming trial in proceedings against the steel giant's former directors over its $4 billion collapse, despite his other role as a party in the case.
A Victorian barrister has reached a settlement on the eve of trial in a breach of fiduciary duty lawsuit brought by a former client who lost a court case over a $24.5 million real estate dispute.
The Federal Court has delayed a 15-day hearing in a pneumococcal vaccine patent dispute between Merck Sharp & Dohme and Pfizer after the sudden death of a family member of one of Pfizer's expert witnesses.